中西医综合疗法预防经皮冠状动脉介入治疗术后
周进才 程明静
（中国人民解放军第153中心医院，河南 郑州，450007）
中图分类号：R256.22 文献标识码：A 文章编号：1674-7860（2016）15-0029-03 证型：BDG
【摘 要】目的：探讨中西医综合疗法预防经皮冠状动脉介入治疗（PCI）术后再狭窄（RS）的临床疗效。方法：选取2013年4月—2015年7月我院收治的68例行PCI术后的冠心病患者，随机分为对照组与观察组，每组34例，对照组给予常规药物治疗，观察组在对照组的基础上给予七味三芎汤。治疗6个月后，比较两组患者治疗总有效率、再狭窄发生率。结果：观察组的再狭窄发生率（2.9%）低于对照组（14.7%），具有统计学差异（P＜0.05）；观察组的治疗总有效率（97.1%）高于对照组（76.4%），具有统计学差异（P＜0.05）。结论：中西医综合疗法可减少PCI术后RS的发生，安全有效，值得在临床上推广使用。
【关键词】中西医综合；经皮冠状动脉介入治疗（PCI）；再狭窄（RS）；疗效
【Abstract】Objective:To explore the clinical effect ofcombined therapy of Chinese and Western Medicine on the prevention ofrestenosis (RS) after percutaneous coronary intervention (PCI). Methods: Atotal of 68 patients with coronary heart disease (CHD) after PCI, admitted toour hospital from April 2013 to July 2015, were randomized into the controlgroup and the observation group, with 34 cases in each group, the control groupwas given routine drug treatment while the observation group received Qiwei Sanqiongdecoction on the basis of the treatment of the control group. After 6 months’treatment, the total effective rate and the incidence of restenosis of twogroups were compared.Results: Therestenosis incidence of the observation group (2.9%) was lower than that ofcontrol group (14.7%), the difference was of statistical significance (P<0.05); the total effective rate ofthe observation group (97.1%) was higher than that of the control group(76.4%), the difference was of statistical significance (P<0.05). Conclusion:IntegratedTraditional Chinese and Western medicine therapy could reduce the occurrence ofRS after PCI, it was safe, effective, and was worthy of being popularized inclinical application.
【Keywords】Integratedtraditional Chinese and Western medicine; Percutaneous coronary intervention(PCI); Restenosis (RS); Curative effect
doi:10.3969/j.issn.1674-7860.2016.15.014
参考文献：
[1]中华医学会心血管病学分会介入心脏病学组,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南2012(简本)[J].中华心血管病杂志,2012 ,40(4):271-277.
[2]何明菊.DE-CMR对心肌梗死的诊断和鉴别诊断及对梗死范围评估的价值探讨[J].昆明医科大学学报,2014,5(9):101.
[3]顾文明,陈德盛,张文吉,等.fQRS、Tp-ec、QTd与急性心肌梗死PCI术后恶性心律失常发生的关系[J].中华全科医学,2013,45(5):684-687.
[4]汪雁博.ST段抬高心肌梗死溶栓后早期冠脉介入治疗对心肌灌注的影响及山莨菪碱的心肾保护作用[J].河北医科大学学报,2012,4(2):273.
[5]杨丽峰,吕吉元,贾永平.经皮冠状动脉介入治疗对急性冠状动脉综合征患者内皮功能的影响[J].中国动脉硬化杂志,2005,13(4):487-490.
[6]孙巧冰.经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者围手术期发生电风暴的危险因素预测[J] .大连医科大学学报,2014,5(11):183.
[7]李远,王涛,张洁芳,等.尼可地尔对冠状动脉慢血流患者血管内皮功能的影响[J].临床荟萃,2013,28(7):728-731.
 |
